Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Zhejiang Hengkang Pranlukast Hydrate

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Pranlukast

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Onon

    02 2Onon Capsules

    03 1Onon Dry Syrup

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Onon Capsules

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon Capsules

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharma

    Pranlukast

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2020 Revenue in Millions : 28

    2019 Revenue in Millions : 36

    Growth (%) : -24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Onon

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharma

    Pranlukast

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2021 Revenue in Millions : 31

    2020 Revenue in Millions : 26

    Growth (%) : 28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Onon

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharmaceuticals

    Pranlukast

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2022 Revenue in Millions : 20

    2021 Revenue in Millions : 31

    Growth (%) : -36

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Onon

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharmaceuticals

    Pranlukast

    Main Therapeutic Indication : Respiratory Diseases

    Currency : USD

    2023 Revenue in Millions : 5

    2022 Revenue in Millions : 20

    Growth (%) : -73

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Onon

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharmaceuticals

    Pranlukast

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2017 Revenue in Millions : 91

    2016 Revenue in Millions : 112

    Growth (%) : -19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Onon

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharmaceuticals

    Pranlukast

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2018 Revenue in Millions : 66

    2017 Revenue in Millions : 86

    Growth (%) : -23%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Onon Capsules

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon Capsules

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharma

    Pranlukast

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2019 Revenue in Millions : 35

    2018 Revenue in Millions : 41

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Onon Dry Syrup

    Pranlukast

    arrow
    RDD
    Not Confirmed

    Brand Name : Onon Dry Syrup

    Japan
    arrow
    RDD
    Not Confirmed

    Ono Pharma

    Pranlukast

    Main Therapeutic Indication : Respiratory Disorders

    Currency : USD

    2019 Revenue in Millions : 22

    2018 Revenue in Millions : 25

    Growth (%) : -11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.